Roundview Capital »

Corcept Therapeutics Incorporated shares owned by Roundview Capital

Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Roundview Capital from 13F filings

Historical chart of Roundview Capital investment in Corcept Therapeutics Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Corcept Therapeutics Incorporated held by Roundview Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corcept Therapeutics Incorporated by Roundview Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $214k 2.5k 86.95

More positions owned by Roundview Capital

Alphabet Cap Stk Cl C (GOOG)
Apple (AAPL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Vanguard Bd Index Fds Intermed Term (BIV)
Vanguard Scottsdale Fds Inter Term Treas (VGIT)
Micron Technology (MU)
Meta Platforms Cl A (META)

View all positions for Roundview Capital

Top funds holding Corcept Therapeutics Incorporated

BlackRock
Ingalls & Snyder
Renaissance Technologies
Vanguard Portfolio Management
Vanguard Capital Management
Parallel Advisors
FMR
State Street Corporation
AQR Capital Management
Geode Capital Management
First Trust Advisors
Tang Capital Management
UBS Group
Dimensional Fund Advisors
Charles Schwab Investment Management

View all funds holding Corcept Therapeutics Incorporated